Seniors shouldn’t wait until fall for COVID-19 booster vax, federal health officials say
By
Alicia Lasek (f3)
Jul 13, 2022
Receiving another booster shot now will not rule out getting a variant-specific shot in the fall, officials told seniors Tuesday. And a second booster shot provides a higher level of protection, they emphasized.
CDC: Deaths from antibiotic-resistant bacteria jumped 15% in 2020
By
Alicia Lasek (f3)
Jul 13, 2022
The COVID-19 pandemic has “pushed back years of progress” in combating antimicrobial resistance in the United States, the CDC reports.
Asking patients about spirituality a must in ‘value-sensitive’ healthcare, Harvard docs say
By
Alicia Lasek (f3)
Jul 13, 2022
Spirituality affects key illness outcomes such as quality of life and medical care decisions, finds a review by a panel of 27 experts.
Clinical briefs for Wednesday, July 13
By
Alicia Lasek (f3)
Jul 13, 2022
Brexpiprazole reduces agitation in Alzheimer’s, late-stage study finds … Seniors skipping meds due to cost, survey finds … ‘Failure to thrive’ diagnostic code for seniors is problematic and dismissive,...
FDA asks for better booster shots as U.S. plans its fall COVID vaccine strategy
By
Alicia Lasek (f3)
Jul 05, 2022
Updated booster shots must fight new variants that weren’t in play when the original COVID-19 vaccines were made, the FDA has told drugmakers.
Feds stockpile more bebtelovimab for use in high-risk COVID patients
By
Alicia Lasek (f3)
Jul 05, 2022
A new order of the injectable COVID antibody bebtelovimab should meet current demand levels through August, according to the Department of Health and Human Services.
Coronavirus vaccines safeguard people with obesity, but less so in the underweight: study
By
Alicia Lasek (f3)
Jul 05, 2022
Underweight people may have less vaccine-derived immunity due to frailty or immunosuppression, investigators theorize.
Clinical briefs for Tuesday, July 5
By
Alicia Lasek (f3)
Jul 05, 2022
Providers: Fix would speed immigrant nurse validation by months … Long COVID more common in women, adults aged 50 to 60 years, study finds … Late-stage MS drug trial put on hold to examine cases...
Clinicians have a wealth of drug options for tackling seniors’ spine pain, review finds
By
Alicia Lasek (f3)
Jul 01, 2022
Investigators examined the evidence for a wide range of potential drug therapies for pain and have published detailed recommendations.
COVID-19 patients face higher risk of neurodegenerative disorders: study
By
Alicia Lasek (f3)
Jul 01, 2022
People who test positive for COVID-19 are at an increased risk of Alzheimer’s disease, Parkinson’s disease and ischemic stroke, a large new study finds.